SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:kth-155985"
 

Search: id:"swepub:oai:DiVA.org:kth-155985" > A reagent resource ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

A reagent resource to identify proteins and peptides of interest for the cancer community

Haab, B. B. (author)
Paulovich, A. G. (author)
Leigh Anderson, N. (author)
show more...
Clark, A. M. (author)
Downing, G. J. (author)
Hermajakob, H. (author)
LaBaer, J. (author)
Uhlén, Mathias (author)
KTH,Proteomik
show less...
 (creator_code:org_t)
2006
2006
English.
In: Molecular and Cellular Proteomics. - 1535-9476. ; 5:10, s. 1996-2007
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • On the basis of discussions with representatives from all sectors of the cancer research community, the National Cancer Institute (NCI) recognizes the immense opportunities to apply proteomics technologies to further cancer research. Validated and well characterized affinity capture reagents (e.g. antibodies, aptamers, and affibodies) will play a key role in proteomics research platforms for the prevention, early detection, treatment, and monitoring of cancer. To discuss ways to develop new resources and optimize current opportunities in this area, the NCI convened the "Proteomic Technologies Reagents Resource Workshop" in Chicago, IL on December 12-13, 2005. The workshop brought together leading scientists in proteomics research to discuss model systems for evaluating and delivering resources for reagents to support MS and affinity capture platforms. Speakers discussed issues and identified action items related to an overall vision for and proposed models for a shared proteomics reagents resource, applications of affinity capture methods in cancer research, quality control and validation of affinity capture reagents, considerations for target selection, and construction of a reagents database. The meeting also featured presentations and discussion from leading private sector investigators on state-of-the-art technologies and capabilities to meet the user community's needs. This workshop was developed as a component of the NCI's Clinical Proteomics Technologies Initiative for Cancer, a coordinated initiative that includes the establishment of reagent resources for the scientific community. This workshop report explores various approaches to develop a framework that will most effectively fulfill the needs of the NCI and the cancer research community.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Keyword

antibody
biological marker
reagent
biomedical technology assessment
cancer research
conference paper
data base
health care organization
high throughput screening
human
mass spectrometry
nonhuman
priority journal
process development
protein analysis
proteomics
quality control
reproducibility
validation process
workshop
Biomedical Research
Humans
Indicators and Reagents
Neoplasm Proteins
Neoplasms
Peptides
Protein Biosynthesis
Reproducibility of Results

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view